Proven through partnerships.

SAB Biotherapeutics has teamed up with premier partners, respected in their fields and industries, to develop immunotherapies for the treatment and prevention of rare conditions, long-term diseases and global pandemic threats. The diversity of the natural platform spans across human health conditions including oncology, infectious diseases, autoimmune disorders and inflammation.

From establishing standards to developing policy and regulatory framework, SAB is an established thought leader in the biotechnology industry and global health discussion. 


The Biomedical Advanced Research and Development Authority (BARDA)
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies.  


BioSystems Networks / Translational Research (BioSNTR)
BioSNTR is focused on bridging the gap between academia and industry to create a bioeconomy in South Dakota through impact science, via a distributed research initiative based on a systems biology approach and translational research model that advances biotechnology.


Biotechnology Innovation Organization

As the world's largest biotechnology trade association, our members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that are transforming how we heal, fuel and feed the world.


Centers for Disease Control and Prevention (CDC)

The CDC is the national public health institute of the United States. The CDC is a federal agency under the Department of Health and Human Services. Its main goal is to protect public health and safety through the control and prevention of disease, injury, and disability.


The LFB Group (LFB)

Since it was formed in 1994, the LFB Group has been developing, manufacturing and marketing biological medicinal products, for diseases that are always serious and often rare. Now one of the leading European players in biopharmaceutical, LFB's medicinal products are derived from living organisms in three major fields of therapy: immunology, haemostasis. The LFB group is a biopharmaceutical company, one of the rare manufacturers in the world with expertise in different bioproduction techniques, offering plasma-derived medicinal products, recombinant medicinal products and advanced therapy treatments such as cell therapies. LFB is a public company and the Group is growing in a competitive sector, with medicinal products sold in nearly 60 countries. Over 2000 employees of the LFB Group, both in France and worldwide. 


National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency—making important discoveries that improve health and save lives.



National Institute of Allergy and Infectious Diseases
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. NIAID is one of the 27 Institutes and Centers of the National Institutes of Health (NIH). 


Naval Medical Research Center
NMRC enhances the health, safety, readiness, and performation of Navy and Marine Corps personnel through basic and applied biomedical research.


Novavax, Inc.
Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. Our vaccine candidates are genetically engineered three-dimensional nanostructures that incorporate recombinant proteins critical to disease pathogenesis. 


rEVO Biologics, Inc. 
rEVO Biologics is a company within the LFB Group, focused on the development of innovative therapeutics for rare diseases and commercialization in the United States. rEVO is bringing to the market therapeutics that make a real difference in the lives of patients. Their unique, patient-driven approach to therapeutics enables expanded access to novel therapies for the treatment of rare diseases. 



Sanford Health
Sanford Health is an integrated health system headquartered in the Dakotas and is now the largest, rural, not-for-profit health care system in the nation with locations in 126 communities in eight states. In addition, Sanford Health is in the process of developing international clinics in Ghana, Israel and Mexico. Sanford Health includes 35 hospitals, 140 clinic locations and 1,360 physicians in 81 specialty areas of medicine. With more than 26,000 employees, Sanford Health is the largest employer in North and South Dakota. 


South Dakota Biotech

South Dakota Biotech is the state affiliate of the Biotech Innovation Organization, the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations. Formed in 2006, this non-profit organization is dedicated to developing biotechnology through expanding research, advocacy, funding, education, infrastructure development and promotion.


World Health Organization (WHO)

WHO is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends.